학술논문
Should autologous hematopoietic stem cell transplantation be offered as a first-line disease modifying therapy to patients with multiple sclerosis?
Document Type
Review Article
Source
In Multiple Sclerosis and Related Disorders August 2023
Subject
Language
ISSN
2211-0348